Clear 489 Results Filter Filter Results Type: Press Release Abiomed Announces Q4 FY 2018 Revenue of $174 Million Up 40% and Total Year Revenue of $594 Million Up 33% Over Prior Year Type: Press Release Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification Type: Press Release Abiomed Announces European Approval (CE Marking) for Impella 55™ and First Patient Treated at University Heart Center Hamburg Type: Press Release Abiomed Receives FDA Approval for Impella CP® with SmartAssist™ and Optical Sensor Type: Press Release Abiomed to Appoint New Chief Financial Officer Todd A Trapp Type: Press Release Abiomed Showcases Impella® Technology that Enables Heart Recovery at ACC with 25 Presentations Type: Press Release Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures Type: Press Release Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Womens Initiative for Heart Recovery Type: Press Release Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock Type: Press Release Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million Up 34% Over Prior Year … 5 6 7 8 …
